|
2013-07-02 |
2013-07-01 |
V
Vente
|
Halstead Michael
Senior V.P., Corp. Development
Dirigeant
|
82 756
+10.2%
108,87
1 066 192 $US
|
82 756
+10.2%
|
108,87
|
1 066 192 $US
|
|
|
2013-07-02 |
2013-07-01 |
V
Vente
|
Sullivan Ryan T
VP, General Counsel & Secr.
Dirigeant
|
58 431
-5.3%
165,14
2 390 387 $US
|
58 431
-5.3%
|
165,14
|
2 390 387 $US
|
|
|
2013-04-01 |
2013-04-01 |
V
Vente
|
van Zoonen Marinus Johannes
President, Europe/Int'l & Mkt.
|
31 845
-22.5%
309,40
3 912 018 $US
|
31 845
-22.5%
|
309,40
|
3 912 018 $US
|
|
|
2013-03-06 |
2013-03-04 |
V
Vente
|
CONNAUGHTON JOHN
Administrateur non-exécutif
|
10 590 608
-100.0%
13,47
142 655 490 $US
|
10 590 608
-100.0%
|
13,47
|
142 655 490 $US
|
|
|
2013-03-04 |
2013-03-01 |
V
Vente
|
Ellman Herman
Senior V.P., Clinical Devel.
Dirigeant
|
1 666
-0.9%
13,38
22 293 $US
|
1 666
-0.9%
|
13,38
|
22 293 $US
|
|
|
2013-03-01 |
2013-02-28 |
V
Vente
|
van Zoonen Marinus Johannes
President, Europe/Int'l & Mkt.
Dirigeant
|
15 869
-9.8%
13,46
213 655 $US
|
15 869
-9.8%
|
13,46
|
213 655 $US
|
|
|
2013-03-01 |
2013-02-28 |
V
Vente
|
Fenton Andrew
Senior V.P., CIO
Dirigeant
|
1 390
-1.3%
13,46
18 715 $US
|
1 390
-1.3%
|
13,46
|
18 715 $US
|
|
|
2013-03-01 |
2013-02-28 |
V
Vente
|
Cross Leland H
Senior V.P., Tech. Operations
Dirigeant
|
1 324
-0.6%
13,46
17 826 $US
|
1 324
-0.6%
|
13,46
|
17 826 $US
|
|
|
2013-03-01 |
2013-02-28 |
V
Vente
|
Halstead Michael
Senior V.P., Corp. Development
Dirigeant
|
1 747
-3.2%
13,46
23 521 $US
|
1 747
-3.2%
|
13,46
|
23 521 $US
|
|
|
2013-03-01 |
2013-02-28 |
V
Vente
|
Rodriguez Rama Francisco
Senior V.P., Tech. Operations
Dirigeant
|
820
-2.6%
13,46
11 040 $US
|
820
-2.6%
|
13,46
|
11 040 $US
|
|
|
2013-03-01 |
2013-02-28 |
V
Vente
|
Herendeen Paul
Exec. V.P. and CFO
Dirigeant
|
4 674
-3.4%
13,46
62 929 $US
|
4 674
-3.4%
|
13,46
|
62 929 $US
|
|
|
2013-03-01 |
2013-02-28 |
V
Vente
|
Boissonneault Roger M
CEO & President
Administrateur exécutif
|
18 730
-0.8%
13,46
252 175 $US
|
18 730
-0.8%
|
13,46
|
252 175 $US
|
|
|
2013-03-01 |
2013-02-28 |
V
Vente
|
Fuhrmann Rochelle
Senior V.P., Finance
Dirigeant
|
1 728
-3.0%
13,46
23 265 $US
|
1 728
-3.0%
|
13,46
|
23 265 $US
|
|
|
2013-03-01 |
2013-02-28 |
V
Vente
|
Howard Alvin D
Sr. V.P., Regulatory Affairs
Dirigeant
|
1 728
-1.7%
13,46
23 265 $US
|
1 728
-1.7%
|
13,46
|
23 265 $US
|
|
|
2013-03-01 |
2013-02-28 |
V
Vente
|
Gilligan Claire A
Senior V.P., Quality
Dirigeant
|
2 354
-2.9%
13,46
31 694 $US
|
2 354
-2.9%
|
13,46
|
31 694 $US
|
|
|
2013-02-21 |
2013-02-19 |
V
Vente
|
Boissonneault Roger M
CEO & President
Administrateur exécutif
|
7 928
-0.3%
14,53
115 176 $US
|
7 928
-0.3%
|
14,53
|
115 176 $US
|
|
|
2013-02-21 |
2013-02-19 |
V
Vente
|
Herendeen Paul
Exec. V.P. and CFO
Dirigeant
|
1 969
-1.4%
14,53
28 605 $US
|
1 969
-1.4%
|
14,53
|
28 605 $US
|
|
|
2013-02-21 |
2013-02-19 |
V
Vente
|
Fenton Andrew
Senior V.P., CIO
Dirigeant
|
419
-0.4%
14,53
6 087 $US
|
419
-0.4%
|
14,53
|
6 087 $US
|
|
|
2013-02-21 |
2013-02-19 |
V
Vente
|
Gilligan Claire A
Senior V.P., Quality
Dirigeant
|
1 045
-1.3%
14,53
15 181 $US
|
1 045
-1.3%
|
14,53
|
15 181 $US
|
|
|
2013-02-21 |
2013-02-19 |
V
Vente
|
Howard Alvin D
Sr. V.P., Regulatory Affairs
Dirigeant
|
767
-0.8%
14,53
11 143 $US
|
767
-0.8%
|
14,53
|
11 143 $US
|
|
|
2013-02-21 |
2013-02-19 |
V
Vente
|
Halstead Michael
Senior V.P., Corp. Development
Dirigeant
|
419
-0.8%
14,53
6 087 $US
|
419
-0.8%
|
14,53
|
6 087 $US
|
|
|
2013-02-21 |
2013-02-19 |
V
Vente
|
Ellman Herman
Senior V.P., Clinical Devel.
Dirigeant
|
691
-0.4%
14,53
10 039 $US
|
691
-0.4%
|
14,53
|
10 039 $US
|
|
|
2013-02-21 |
2013-02-19 |
V
Vente
|
Fuhrmann Rochelle
Senior V.P., Finance
Dirigeant
|
767
-1.3%
14,53
11 143 $US
|
767
-1.3%
|
14,53
|
11 143 $US
|
|
|
2013-02-21 |
2013-02-19 |
V
Vente
|
van Zoonen Marinus Johannes
President, Europe/Int'l & Mkt.
Dirigeant
|
2 562
-1.9%
14,53
37 220 $US
|
2 562
-1.9%
|
14,53
|
37 220 $US
|
|
|
2013-02-21 |
2013-02-19 |
V
Vente
|
Cross Leland H
Senior V.P., Tech. Operations
Dirigeant
|
553
-0.3%
14,53
8 034 $US
|
553
-0.3%
|
14,53
|
8 034 $US
|
|
|
2013-02-04 |
2013-02-01 |
V
Vente
|
Boissonneault Roger M
CEO & President
Administrateur exécutif
|
9 125
-0.4%
14,18
129 376 $US
|
9 125
-0.4%
|
14,18
|
129 376 $US
|
|
|
2013-02-04 |
2013-02-01 |
V
Vente
|
Fuhrmann Rochelle
Senior V.P., Finance
Dirigeant
|
998
-2.2%
14,18
14 150 $US
|
998
-2.2%
|
14,18
|
14 150 $US
|
|
|
2013-02-04 |
2013-02-01 |
V
Vente
|
Howard Alvin D
Sr. V.P., Regulatory Affairs
Dirigeant
|
1 010
-1.2%
14,18
14 320 $US
|
1 010
-1.2%
|
14,18
|
14 320 $US
|
|
|
2013-02-04 |
2013-02-01 |
V
Vente
|
Herendeen Paul
Exec. V.P. and CFO
Dirigeant
|
2 840
-2.7%
14,18
40 266 $US
|
2 840
-2.7%
|
14,18
|
40 266 $US
|
|
|
2013-02-04 |
2013-02-01 |
V
Vente
|
Halstead Michael
Senior V.P., Corp. Development
Dirigeant
|
998
-2.5%
14,18
14 150 $US
|
998
-2.5%
|
14,18
|
14 150 $US
|
|
|
2013-02-04 |
2013-02-01 |
V
Vente
|
Gilligan Claire A
Senior V.P., Quality
Dirigeant
|
1 377
-2.1%
14,18
19 523 $US
|
1 377
-2.1%
|
14,18
|
19 523 $US
|
|
|
2013-02-04 |
2013-02-01 |
V
Vente
|
Ellman Herman
Senior V.P., Clinical Devel.
Dirigeant
|
1 010
-0.6%
14,18
14 320 $US
|
1 010
-0.6%
|
14,18
|
14 320 $US
|
|
|
2013-02-04 |
2013-02-01 |
V
Vente
|
Fenton Andrew
Senior V.P., CIO
Dirigeant
|
996
-1.0%
14,18
14 121 $US
|
996
-1.0%
|
14,18
|
14 121 $US
|
|
|
2013-02-04 |
2013-02-01 |
V
Vente
|
Cross Leland H
Senior V.P., Tech. Operations
Dirigeant
|
808
-0.4%
14,18
11 456 $US
|
808
-0.4%
|
14,18
|
11 456 $US
|
|
|
2013-02-04 |
2013-02-01 |
V
Vente
|
van Zoonen Marinus Johannes
President, Europe/Int'l & Mkt.
Dirigeant
|
13 790
-9.4%
14,18
195 517 $US
|
13 790
-9.4%
|
14,18
|
195 517 $US
|
|
|
2013-01-31 |
2013-01-30 |
V
Vente
|
van Zoonen Marinus Johannes
President, Europe/Int'l & Mkt.
Dirigeant
|
308
-0.2%
13,38
4 122 $US
|
308
-0.2%
|
13,38
|
4 122 $US
|
|
|
2013-01-31 |
2013-01-30 |
V
Vente
|
Fenton Andrew
Senior V.P., CIO
Dirigeant
|
351
-0.4%
13,38
4 698 $US
|
351
-0.4%
|
13,38
|
4 698 $US
|
|
|
2013-01-31 |
2013-01-30 |
V
Vente
|
Gilligan Claire A
Senior V.P., Quality
Dirigeant
|
489
-0.7%
13,38
6 545 $US
|
489
-0.7%
|
13,38
|
6 545 $US
|
|
|
2013-01-31 |
2013-01-30 |
V
Vente
|
Halstead Michael
Senior V.P., Corp. Development
Dirigeant
|
320
-0.8%
13,38
4 283 $US
|
320
-0.8%
|
13,38
|
4 283 $US
|
|
|
2013-01-31 |
2013-01-30 |
V
Vente
|
Howard Alvin D
Sr. V.P., Regulatory Affairs
Dirigeant
|
591
-0.7%
13,38
7 910 $US
|
591
-0.7%
|
13,38
|
7 910 $US
|
|
|
2013-01-31 |
2013-01-30 |
V
Vente
|
van Zoonen Marinus Johannes
President, Europe/Int'l & Mkt.
Dirigeant
|
1 907
-1.3%
14,42
27 499 $US
|
1 907
-1.3%
|
14,42
|
27 499 $US
|
|
|
2013-01-31 |
2013-01-30 |
V
Vente
|
Cross Leland H
Senior V.P., Tech. Operations
Dirigeant
|
465
-0.2%
13,38
6 224 $US
|
465
-0.2%
|
13,38
|
6 224 $US
|
|
|
2013-01-31 |
2013-01-30 |
V
Vente
|
Ellman Herman
Senior V.P., Clinical Devel.
Dirigeant
|
586
-0.3%
13,38
7 843 $US
|
586
-0.3%
|
13,38
|
7 843 $US
|
|
|
2013-01-31 |
2013-01-30 |
V
Vente
|
Fuhrmann Rochelle
Senior V.P., Finance
Dirigeant
|
282
-0.6%
13,38
3 774 $US
|
282
-0.6%
|
13,38
|
3 774 $US
|
|
|
2013-01-31 |
2013-01-30 |
V
Vente
|
Herendeen Paul
Exec. V.P. and CFO
Dirigeant
|
2 208
-2.1%
13,38
29 552 $US
|
2 208
-2.1%
|
13,38
|
29 552 $US
|
|
|
2013-01-31 |
2013-01-30 |
V
Vente
|
Boissonneault Roger M
CEO & President
Administrateur exécutif
|
8 470
-0.4%
13,38
113 363 $US
|
8 470
-0.4%
|
13,38
|
113 363 $US
|
|
|
2013-01-23 |
2013-01-22 |
V
Vente
|
Boissonneault Roger M
CEO & President
Administrateur exécutif
|
13 924
-0.6%
13,50
187 973 $US
|
13 924
-0.6%
|
13,50
|
187 973 $US
|
|
|
2013-01-23 |
2013-01-22 |
V
Vente
|
Gilligan Claire A
Senior V.P., Quality
Dirigeant
|
949
-1.4%
13,50
12 811 $US
|
949
-1.4%
|
13,50
|
12 811 $US
|
|
|
2013-01-23 |
2013-01-22 |
V
Vente
|
Cross Leland H
Senior V.P., Tech. Operations
Dirigeant
|
839
-0.4%
13,50
11 326 $US
|
839
-0.4%
|
13,50
|
11 326 $US
|
|
|
2013-01-23 |
2013-01-22 |
V
Vente
|
Herendeen Paul
Exec. V.P. and CFO
Dirigeant
|
4 305
-3.9%
13,50
58 117 $US
|
4 305
-3.9%
|
13,50
|
58 117 $US
|
|
|
2013-01-23 |
2013-01-22 |
V
Vente
|
Halstead Michael
Senior V.P., Corp. Development
Dirigeant
|
488
-1.2%
13,50
6 588 $US
|
488
-1.2%
|
13,50
|
6 588 $US
|
|
|
2013-01-23 |
2013-01-22 |
V
Vente
|
Howard Alvin D
Sr. V.P., Regulatory Affairs
Dirigeant
|
1 222
-1.4%
13,50
16 497 $US
|
1 222
-1.4%
|
13,50
|
16 497 $US
|
|
|
2013-01-23 |
2013-01-22 |
V
Vente
|
Fuhrmann Rochelle
Senior V.P., Finance
Dirigeant
|
488
-1.1%
13,50
6 588 $US
|
488
-1.1%
|
13,50
|
6 588 $US
|
|
|
2013-01-23 |
2013-01-22 |
V
Vente
|
Fenton Andrew
Senior V.P., CIO
Dirigeant
|
621
-0.6%
13,50
8 383 $US
|
621
-0.6%
|
13,50
|
8 383 $US
|
|
|
2013-01-23 |
2013-01-22 |
V
Vente
|
Ellman Herman
Senior V.P., Clinical Devel.
Dirigeant
|
1 166
-0.7%
13,50
15 741 $US
|
1 166
-0.7%
|
13,50
|
15 741 $US
|
|
|
2012-10-01 |
2012-10-01 |
V
Vente
|
Gilligan Claire A
Senior V.P., Quality
Dirigeant
|
264
-0.4%
13,55
3 577 $US
|
264
-0.4%
|
13,55
|
3 577 $US
|
|
|
2012-10-01 |
2012-10-01 |
V
Vente
|
Halstead Michael
Senior V.P., Corp. Development
Dirigeant
|
77
-0.2%
13,55
1 043 $US
|
77
-0.2%
|
13,55
|
1 043 $US
|
|
|
2012-09-13 |
2012-09-11 |
V
Vente
|
THL WC (Dutch) B.V.
Actionnaire important
|
14 000 000
-54.9%
13,10
183 400 000 $US
|
14 000 000
-54.9%
|
13,10
|
183 400 000 $US
|
|
|
2012-09-13 |
2012-09-11 |
V
Vente
|
ABBRECHT TODD M
Administrateur non-exécutif
|
14 000 000
-54.9%
13,10
183 400 000 $US
|
14 000 000
-54.9%
|
13,10
|
183 400 000 $US
|
|
|
2012-09-13 |
2012-09-11 |
V
Vente
|
CONNAUGHTON JOHN
Administrateur non-exécutif
Actionnaire important
|
12 890 449
-52.9%
13,10
168 864 882 $US
|
12 890 449
-52.9%
|
13,10
|
168 864 882 $US
|
|
|
2012-09-13 |
2012-09-11 |
V
Vente
|
BAIN CAPITAL INVESTORS LLC
Actionnaire important
|
12 890 449
-52.9%
13,10
168 864 882 $US
|
12 890 449
-52.9%
|
13,10
|
168 864 882 $US
|
|
|
2012-09-12 |
2012-09-11 |
V
Vente
|
Herendeen Paul
Exec. V.P. and CFO
Dirigeant
|
309 240
-73.6%
13,10
4 051 044 $US
|
309 240
-73.6%
|
13,10
|
4 051 044 $US
|
|
|
2012-09-12 |
2012-09-11 |
V
Vente
|
Hara Izumi
Senior V.P.
Dirigeant
|
126 993
-63.2%
13,10
1 663 608 $US
|
126 993
-63.2%
|
13,10
|
1 663 608 $US
|
|
|
2012-09-12 |
2012-09-11 |
V
Vente
|
Ellman Herman
Senior V.P., Clinical Devel.
Dirigeant
|
23 500
-12.1%
13,10
307 850 $US
|
23 500
-12.1%
|
13,10
|
307 850 $US
|
|
|
2012-09-12 |
2012-09-11 |
V
Vente
|
Howard Alvin D
Sr. V.P., Regulatory Affairs
Dirigeant
|
147 639
-62.2%
13,10
1 934 071 $US
|
147 639
-62.2%
|
13,10
|
1 934 071 $US
|
|
|
2012-09-11 |
2012-09-11 |
V
Vente
|
JPMP MASTER FUND MANAGER L P
Actionnaire important
|
1 497 803
-68.9%
13,10
19 621 219 $US
|
1 497 803
-68.9%
|
13,10
|
19 621 219 $US
|
|
|
2012-09-11 |
2012-09-11 |
V
Vente
|
JPMP MASTER FUND MANAGER L P
Actionnaire important
|
215 401
-54.9%
13,10
2 821 753 $US
|
215 401
-54.9%
|
13,10
|
2 821 753 $US
|
|
|
2012-09-11 |
2012-09-11 |
V
Vente
|
JPMP MASTER FUND MANAGER L P
Actionnaire important
|
950 124
-54.9%
13,10
12 446 624 $US
|
950 124
-54.9%
|
13,10
|
12 446 624 $US
|
|
|
2012-09-11 |
2012-09-11 |
V
Vente
|
JPMP MASTER FUND MANAGER L P
Actionnaire important
|
193 470
-68.9%
13,10
2 534 457 $US
|
193 470
-68.9%
|
13,10
|
2 534 457 $US
|
|
|
2012-09-11 |
2012-09-11 |
V
Vente
|
JPMP MASTER FUND MANAGER L P
Actionnaire important
|
1 145 303
-54.9%
13,10
15 003 469 $US
|
1 145 303
-54.9%
|
13,10
|
15 003 469 $US
|
|
|
2012-09-11 |
2012-09-11 |
V
Vente
|
JPMP MASTER FUND MANAGER L P
Actionnaire important
|
266 987
-54.9%
13,10
3 497 530 $US
|
266 987
-54.9%
|
13,10
|
3 497 530 $US
|
|
|
2012-09-11 |
2012-09-11 |
V
Vente
|
JPMP MASTER FUND MANAGER L P
Actionnaire important
|
373 782
-54.9%
13,10
4 896 544 $US
|
373 782
-54.9%
|
13,10
|
4 896 544 $US
|
|
|
2012-09-11 |
2012-09-11 |
V
Vente
|
JPMP MASTER FUND MANAGER L P
Actionnaire important
|
2 224 741
-54.9%
13,10
29 144 107 $US
|
2 224 741
-54.9%
|
13,10
|
29 144 107 $US
|
|
|
2012-09-11 |
2012-09-11 |
V
Vente
|
JPMP MASTER FUND MANAGER L P
Actionnaire important
|
7 894 814
-54.9%
13,10
103 422 063 $US
|
7 894 814
-54.9%
|
13,10
|
103 422 063 $US
|
|
|
2012-09-11 |
2012-09-11 |
V
Vente
|
JP MORGAN PARTNERS BHCA LP
Actionnaire important
|
1 497 803
-68.9%
13,10
19 621 219 $US
|
1 497 803
-68.9%
|
13,10
|
19 621 219 $US
|
|